SHE:002873 - Guiyang Xintian Pharmaceutical Co Ltd

Guiyang Xintian Pharmaceutical
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	239.37M 11.5%	291.23M 21.7%	224.58M -22.9%	249.22M 11.0%	275.32M 10.5%	344.7M 25.2%	218.44M -36.6%	208.76M -4.4%	317.15M 51.9%	249.76M -21.2%	178.32M -28.6%	177.32M -0.6%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	49.96M 15.0%	60.25M 20.6%	47.5M -21.2%	51.42M 8.3%	61.61M 19.8%	80.56M 30.8%	53.69M -33.4%	45.79M -14.7%	74.55M 62.8%	57.03M -23.5%	41.39M -27.4%	39.31M -5.0%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	189.42M 10.6%	230.99M 21.9%	177.08M -23.3%	197.79M 11.7%	213.71M 8.0%	264.13M 23.6%	164.75M -37.6%	162.97M -1.1%	242.6M 48.9%	192.73M -20.6%	136.92M -29.0%	138.01M 0.8%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	207.86M 15.8%	241.12M 16.0%	204.59M -15.1%	210.65M 3.0%	240.57M 14.2%	289.71M 20.4%	208.17M -28.1%	178.86M -14.1%	281.54M 57.4%	196.7M -30.1%	193.08M -1.8%	154.06M -20.2%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	157.91M 16.1%	180.87M 14.5%	157.09M -13.1%	159.23M 1.4%	178.96M 12.4%	209.14M 16.9%	154.48M -26.1%	133.07M -13.9%	207M 55.5%	139.67M -32.5%	151.69M 8.6%	114.75M -24.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	31.51M -10.5%	50.12M 59.0%	19.99M -60.1%	38.57M 93.0%	34.75M -9.9%	54.99M 58.2%	10.27M -81.3%	29.89M 191.2%	35.61M 19.1%	53.06M 49.0%	-14.77M -	23.26M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	46.84M -	-	-	-	57.45M -	-	-	-	46.33M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.47M -15.4%	42.1M 96.1%	10.54M -75.0%	30.88M 192.9%	26.57M -14.0%	47.44M 78.6%	6.63M -86.0%	25.09M 278.4%	21.24M -15.4%	41.38M 94.9%	-6.84M -	15.57M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.096 -14.9%	0.185 92.5%	0.043 -76.5%	0.133 206.8%	0.114 -14.2%	0.204 78.8%	0.029 -86.0%	0.108 278.3%	0.091 -15.4%	0.178 95.1%	-0.029 -	0.067 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.09 -16.3%	0.177 96.3%	0.032 -81.7%	0.125 286.8%	0.107 -14.1%	0.191 77.4%	0.029 -85.0%	0.102 257.0%	0.087 -15.2%	0.167 93.1%	-0.029 -	0.062 -